belcesiran
belcesiran: sourced relationships with 1 company · 1 clinical trial tracked.
belcesiran evidence translation
What we can confirm
1 tracked trial
What it means
What to watch
Prepared research question
How could belcesiran → DRNA affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Dicerna Pharmaceuticals Inc (DRNA) | Phase 2 |
Clinical Trial Registry Records (1)
A Phase 2, Randomized, Double-blind, Placebo-Controlled Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Dose Levels of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Primary endpoint: Number of Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)
Frequently asked questions
Which companies have sourced relationships with belcesiran?
belcesiran has dated SEC/FDA relationship records for Dicerna Pharmaceuticals Inc.
How many clinical trials involve belcesiran?
BioSniper tracks 1 clinical trial involving belcesiran.